Roche (SIX: RO, ROG; OTCQX: RHHBY) will showcase a laboratory of the future exhibit at the 2024 Association for Diagnostics & Laboratory Medicine (ADLM) Scientific Meeting and Clinical Lab Expo, July 28 through August...

BillionToOne, a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, is thrilled to announce a new publication that shows cfDNA analysis is highly sensitive and...

ReviR Therapeutics, an AI-enabled biotechnology company focused on developing small molecule RNA modulators for neurogenetic diseases, announced today that it has successfully completed a $30 million Series A financing,...

HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company committed to discovering and developing innovative medicines for patients, reported financial results for the second quarter of 2024 and...

Waterdrop, a leading provider of innovative water filtration systems, is pleased to announce its partnership with The Water Project, a non-profit organization dedicated to providing reliable water projects in sub-Saharan...

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic,...

Titan America's two cement campuses were recognized for energy and environmental performances at PCA's annual fly-in and awards program held in Washington, DC. Every year cement industry leaders meet with...

Angel Yeast (SH600298), a global leader in yeast manufacturing, recently introduced its yeast protein and innovative application solutions at the Growth Asia 2024 summit, which was co-hosted by leading industry media...

Renew Biotechnologies, a leading biotech company dedicated to pioneering NGS-based diagnostic solutions, appoints Steven Abbott as Chief Operating Officer (COO). Mr. Abbott brings extensive experience in genomics and...

Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2024 financial results on Aug. 8, 2024. Lilly will also conduct a conference call that day with the investment community and media to further detail the...

The pioneering initiative to improve access to blue finance projects, forged late last year from the partnership between T. Rowe Price, a global investment management firm and leader in retirement, and International...

ITF Therapeutics LLC, the U.S.-based rare disease commercial arm of Italfarmaco, today announced the U.S. commercial launch of DUVYZAT™ (givinostat), a histone deacetylase inhibitor, for the treatment of patients six years...

Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, and Reworld,™ a leading sustainable waste solutions company, today announced a strategic partnership. This...

Analog Devices, Inc. (Nasdaq: ADI), a global semiconductor leader, and Flagship Pioneering, the bioplatform innovation company, today announced a strategic alliance to accelerate the development of a fully digitized...

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced it will attend two leading industry conferences focused on research and developments for both...

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company will report its second quarter...

Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to RAG-18,...

AbbVie (NYSE:ABBV) announced financial results for the second quarter ended June 30, 2024.

Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will report its second quarter 2024 financial results and...

Bio-Thera Solutions Inc. (688177: SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today announced that dosing has recently begun in an integrated Phase I /...

T3D Therapeutics, Inc., a clinical stage drug development company engaged in the development of a new orally administered treatment for Alzheimer's disease (AD), today announced that Dr. Robert Alexander has joined the...

The highly anticipated season finale of Hulu's 'The Kardashians,' releasing at 12:00am ET on July 25, 2024, features the celebrity family exploring cutting-edge health interventions focused on longevity. During...

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologics License Application (sBLA) for BRINEURA® (cerliponase alfa)...

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that OncoHelix, an internationally recognized research and diagnostics laboratory for...

Advancion Corporation ("Advancion" or "Company"), a leading global producer of specialty ingredients for the life sciences, home and personal care, and other consumer-oriented and industrial markets, today announced it has...

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that OncoHelix, an internationally recognized research and diagnostics laboratory for...

Inimmune, a clinical stage biotech company focused on the development of novel immunotherapies, vaccines, and vaccine adjuvants announced today the dosing of the first patient in its Phase 1 single ascending dose study of...

Datavant, the leading health data platform company, announced today its upcoming participation in the Artificial Intelligence (AI) Demonstration Day reception on July 25, 2024. This prestigious event, hosted by AdvaMed,...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that it will host a conference call and webcast on Thursday, August 1, 2024,...

Beacon Therapeutics Holdings Limited ('Beacon' or 'the Company'), a leading ophthalmic gene therapy company with a mission to save and restore the vision of patients with blinding retinal diseases, today...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced it has signed an agreement with LTS Therapy Systems, LLC ("LTS"), to develop and manufacture the HT-ALZ oral film...

Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today announced that the FDA has accepted the BLA for BAT2206, a proposed...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced the appointment of...

Mars, Incorporated today released the 2023 Mars Sustainable in a Generation Report, announcing notable progress toward its goal of achieving net zero by 2050, registering a record 8% GHG emissions reduction against its...

T3D Therapeutics, Inc., a clinical stage drug development company engaged in the development of a new orally administered treatment for Alzheimer's disease (AD), today announced that CEO, John Didsbury, will be...

MSA Safety, Inc. (NYSE: MSA), a global leader in the development of safety solutions that help to protect people and facility infrastructures, today announced that its 2023 Impact Report is now available on the...

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report second quarter 2024 financial results on Tuesday, August 6,...

Pinetree Therapeutics, Inc. ("Pinetree" or the "Company"), a biotechnology company pioneering next generation targeted protein degraders (TPD) to combat drug resistance in oncology and beyond, today announced it has...

FitBiomics, a leading biotechnology company using microbiome innovation to create next-generation products, announced today a revolutionary advancement in reducing fatigue through gut health optimization with the launch of...

Neuspera Medical, Inc., a neuromodulation company pioneering the Neuspera Implantable Sacral Neuromodulation (SNM) System, announced it has reached a significant milestone: All implanted patients have completed the 6-month...

Debut, the biotech beauty leader, announced today that it has launched BiotechXBeautyLabs™, a trailblazing formulation development and contract manufacturing business that creates next-generation high-performing,...

Midland, the leader in two-way radio communications technology, is excited to announce its three-year sponsorship with Experience Camps. This sponsorship underscores Midland's dedication to safety, education, and...

The life science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announces its comprehensive suite of eco-conscious, cost-effective...

Orange Grove Bio, a leading integrated biopharmaceutical company, and the University of Chicago's Polsky Center for Entrepreneurship and Innovation today announced a strategic partnership to catalyze the successful...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its collaborator, Moffitt Cancer Center (Moffitt), has...

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, August 5, 2024, at 4:30 p.m. ET to...

Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, is pleased to announce its revenue projections for key product lines through the year 2029.

Waters Corporation (NYSE: WAT) announced today the global release of the TA Instruments™ Rapid Screening-Differential Scanning Calorimeter (TA Instruments RS-DSC), designed for biopharmaceutical developers. The TA...

Allucent today announced that it has appointed industry veteran Paula Brown Stafford as chief executive officer to advance the next phase of its expansion. Ms. Stafford succeeds Mark A. Goldberg, M.D., in a planned...

Third Arc Bio Inc., a biotech company developing multifunctional antibodies that are optimized for best-in-class T cell engagement across solid tumors and inflammatory & immunology (I&I) disease, today announced a...

Flagship Pioneering, the bioplatform innovation company, today unveiled Abiologics, a company reimagining biologics with the creation of a new class of supranatural and programmable medicines, called Synteins™. Synteins...

Cytoki Pharma, ApS (Cytoki), a clinical-stage biotechnology company pioneering a new class of medicines that harness IL-22 biology to drive improved outcomes for metabolic disease, today announced positive data from a...

QDX, a computational drug discovery company, today announced a collaboration with Prelude Therapeutics, a clinical-stage precision oncology company, targeting undisclosed, previously undrugged oncology targets.

Azenta, Inc. (Nasdaq: AZTA) today announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland. The FinnGen project is a pioneering endeavor...

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on July 20, 2024, the...

Precision Biologics, Inc. ("Precision"), a clinical-stage immunotherapy and targeted oncology company, announced today that on July 16, 2024, the USPTO granted another patent for its lead clinical asset, NEO-201, which is...

Latigo Biotherapeutics Inc. ("Latigo"), a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target pain at its source, today announced the appointment of Nima Farzan, MBA, as...

The molecular design strategy and experimental results of Bright Gene's dual GLP-1/GIP receptor agonist, BGM0504, have been published online in Scientific Reports, a sub-journal of Nature, on July 19, 2024. Bright Gene...

Terex Corporation (NYSE: TEX) (the "Company") today announced it has signed a definitive agreement to acquire Environmental Solutions Group ("ESG") from Dover Corporation (NYSE: DOV), in a $2.0 billion all-cash...

Recently, Gan & Lee Pharmaceuticals(Gan & Lee, Shanghai Stock Exchange: 603087) announced that its independently developed long-acting GLP-1 receptor agonist (GLP-1 RA), GZR18 injection, has achieved positive...

FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform, today announced it has released its 2023 Environmental, Social, and Governance (ESG) report, the Company's sixth consecutive...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Graduate School of Medicine / Faculty of Medicine, Osaka University (President: Shojiro Nishio "Osaka University") today announced that...

Full-Life Technologies, a fully integrated global radiotherapeutics company, today announced the appointment of Ted Myles to Full-Life's Board of Directors. Mr. Myles will serve as chairman of the audit committee and...

According to WHO, 528 million people suffer from joint pain. Age, obesity, and sports can lead to cartilage wear and osteoarthritis. While surgery or implants are common treatments, with the USA accountable for about 30%...

Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced today that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem...

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported that it has furnished...

Kia is pleased to announce that it has been named among TIME Magazine's "World's Most Sustainable Companies of 2024."

111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in...

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, today...

Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-course epigenetic editing therapeutics, today announced the appointment of Melissa J. Moore, Ph.D., to its Board of Directors.

Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced a new collaboration agreement with LSU...

MedGenome, a leading provider of multiomics solutions, today announced the acquisition of a PacBio Revio sequencing system. This latest addition to MedGenome's technology portfolio will significantly bolster their...

DX&VX, which is gaining attention for developing an oral GLP-1 obesity treatment. The company is accelerating the optimization of new drug candidates.

Saluda Medical, Inc., a commercial-stage medical device company focused on developing treatments for chronic neurological conditions driven by a novel closed-loop, dose-control neuromodulation platform, today announced the...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the launch of a new sprinkle formulation of INGREZZA® (valbenazine) capsules, the #1 prescribed vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for...

Samyang Corporation is accelerating its efforts to promote specialty (high-functional) ingredients and expand overseas markets by consistently participating in global food-related exhibitions.

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Brittany Davison, CPA, CA as Business Advisor. Ms. Davison is a Chartered Professional Accountant...

On the 18th, LG Innotek (CEO Moon, Hyuksoo) announced that it has successfully converted about 61% of the electricity consumption of its business sites to renewable energy. This was a remarkable achievement in just one...

Boehringer Ingelheim and GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced today a patient affordability initiative to provide citrate-free Adalimumab-adbm, Boehringer's biosimilar...

Windrose Consulting Group, a global strategy consulting firm that partners with life science companies to maximize the commercial value of their products, is thrilled to announce the appointment of Jose Galan, PhD as...

Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx",688373.SH) presented the latest research progress on their novel antibiotic pipeline products, MRX-5 and MRX-8, at the 7th World Bronchiectasis Conference (WBC) held in...

Leading global biotechnology company Amgen, and NSG BioLabs, Singapore's largest provider of biotech co-working biosafety level 2 laboratories, celebrate the successful conclusion of their third annual Amgen Golden...

The 90th China International Medical Equipment Fair (CMEF) is set to take place in Shenzhen from October 12th to 15th, 2024. With an expected attendance of over 200,000 visitors from more than 150 countries, the exhibition...

Avirmax CMC, a leader in the innovation and manufacture of adeno-associated virus (AAV) vector-mediated biotherapeutics, announces the successful delivery to its first client with Good Manufacturing Practice (GMP) lots of...

The EveryLife Foundation for Rare Diseases commends the Food and Drug Administration (FDA) on today's announcement of its intention to create a Rare Disease Innovation Hub. Co-chaired by CDER Director, Dr. Peter Marks,...

Cox Enterprises announced that Anne Lofye has been named senior vice president of Corporate Services & Sustainability, effective immediately.

In June 2024, a surgical team led by Professor Richard Y. Su and Dr. Jane J. Pu from the Faculty of Dentistry at The University of Hong Kong, in collaboration with United Imaging Intelligence (UII), has achieved a...

Aspen Neuroscience, Inc., a clinical-stage private biotechnology company developing personalized regenerative therapies, announced today that president and CEO Damien McDevitt, PhD, will participate in a virtual fireside...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its collaborator, Cleveland Clinic, has received a...

SHINE Technologies, a next-generation fusion company, today announced that it has been awarded $32 million from the Department of Energy's National Nuclear Security Administration (DOE/NNSA). The funding was added to...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today...

HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting regulatory sites on proteins referred to as "natural hotspots," today...

Renalys Pharma, Inc., a late-stage clinical biopharmaceutical company has completed a ¥6.0Bn Series A financing.  The financing was led by Catalys Pacific and SR One, along with additional investors, including JPS Growth...

GCCL, a clinical trial sample analysis institution, has proactively developed pharmacokinetic (PK) analysis methods for blockbuster drugs' biosimilars and offers customized clinical trial analysis services for...

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:

bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes to power the future of the bioeconomy, today announced the addition of John Nicols as a key strategic advisor, further expanding...

"Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery" webinar will be jointly hosted by HitGen Inc. and Xtalks on Wednesday July 17, 2024, at 2pm EDT (11am PDT). Alex Shaginian, PhD,...